home / stock / azyo / azyo news


AZYO News and Press, Aziyo Biologics Inc.

Stock Information

Company Name: Aziyo Biologics Inc.
Stock Symbol: AZYO
Market: NASDAQ

Menu

AZYO AZYO Quote AZYO Short AZYO News AZYO Articles AZYO Message Board
Get AZYO Alerts

News, Short Squeeze, Breakout and More Instantly...

AZYO - Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices

– Company to begin trading under new ticker symbol “ELUT” – SILVER SPRING, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”) today announced a change of the Company’s name to Elutia Inc. The rebranding ref...

AZYO - Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures

Case provides first histologic evidence that CanGaroo can catalyze development of new healthy tissue layer within an existing cardiac implantable electronic device (CIED) pocket SILVER SPRING, Md., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”...

AZYO - Aziyo Biologics, Inc. (AZYO) Q2 2023 Earnings Call Transcript

2023-08-20 12:41:05 ET Aziyo Biologics, Inc. (AZYO) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Matt Steinberg - FINN Partners Randy Mills - President and Chief Executive Officer Matthew Ferguson - Chief Financial Officer ...

AZYO - Aziyo Biologics GAAP EPS of -$0.65 misses by $0.36, revenue of $10.3M misses by $2.2M

2023-08-14 16:09:45 ET Aziyo Biologics press release ( NASDAQ: AZYO ): Q2 GAAP EPS of -$0.65 misses by $0.36 . Revenue of $10.3M (-18.3% Y/Y) misses by $2.2M . For further details see: Aziyo Biologics GAAP EPS of -$0.65 misses by $0.36, revenue of $10.3M ...

AZYO - Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company

Negotiating multiple LOIs to divest Orthopedic business CanGaroo ® RM 510(k) resubmission to the FDA remains on track SimpliDerm ® quarterly net sales up 32% year-over-year Successful transfer of Cardiovascular product distribution to LeMaitre Vascular ...

AZYO - Aziyo Biologics Q2 Earnings Preview

2023-08-13 17:35:00 ET More on Aziyo Biologics Aziyo Biologics, Inc. ( AZYO ) Q1 2023 Earnings Call Transcript Aziyo gains on data for wound healing product in cardiac implantation Aziyo sheds 56% as FDA cites issues in marketing submission for antibacterial prod...

AZYO - Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

SILVER SPRING, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today announced that it will release it...

AZYO - SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update PR Newswire DALLAS , July 17, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and m...

AZYO - Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products

SILVER SPRING, Md., July 13, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today announced a voluntary recall of its viable bone matr...

AZYO - Aziyo gains on data for wound healing product in cardiac implantation

2023-05-19 09:13:45 ET Aziyo Biologics ( NASDAQ: AZYO ) added ~8% pre-market Friday after announcing the study data supporting the potential of its healing product CanGaroo Biologics Envelope when with a cardiac implantable electronic device (CIED). The U.S.-based trial invo...

Next 10